| 标题： | 32周以下早产儿巨细胞病毒感染防治的管理指南 |
| title： | Guideline recommended for management of cytomegalovirus infection in premature infants with gestational age < 32 weeks in China |
| 版本： | 原创版 |
| version： | Original |
| 分类： | 标准指南 |
| classification： | Standard guideline |
| 领域： | 综合 |
| field： | Comprehensive guideline |
| 国家和地区： | 中国 |
| Country and region： | China |
| 指南使用者： | 新生儿科及产科医生 |
| Guide users： | Neonatologist and obstetrician |
| 证据分级方法： | 推荐意见分级的评估、制订及评价方法 |
| Evidence grading method： | Grading of recommendations assessment，development and evaluation，GRADE |
| 制定单位： | Chengdu Women’s and Children’s Central Hospital, School of Medicine, University of Electronic Science and Technology of China |
| Formulating unit： | Chengdu Women’s and Children’s Central Hospital, School of Medicine, University of Electronic Science and Technology of China |
| 注册时间： | 2023-12-25 |
| Registration time： | |
| 注册编号： | PREPARE-2023CN514 |
| Registration number： | |
| 指南制订的目的： | 目前无专门针对32周以下早产儿 规范32周以下早产儿先天性巨细胞病毒感染及获得性巨细胞病毒感染的预防、筛查、诊断、治疗及随访。 |
| Purpose of the guideline： | Prevention, screening, diagnosis, treatment, and follow-up of congenital cytomegalovirus and Post-natal acquisition of cytomegalovirus infection in premature infants with gestational age < 32 weeks |
